Nektar Therapeutics
NKTR
#5687
Rank
$1.15 B
Marketcap
$56.90
Share price
-1.37%
Change (1 day)
271.90%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $0.21 Billion USD

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are $0.21 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.24 B-8.96%
2023-12-31$0.26 B-22.36%
2022-12-31$0.34 B-21.41%
2021-12-31$0.43 B-5.16%
2020-12-31$0.46 B-19.32%
2019-12-31$0.57 B32.22%
2018-12-31$0.43 B2.75%
2017-12-31$0.42 B-12.42%
2016-12-31$0.48 B-2.33%
2015-12-31$0.49 B21.45%
2014-12-31$0.40 B-22.72%
2013-12-31$0.52 B16.34%
2012-12-31$0.45 B10.28%
2011-12-31$0.40 B-5.07%
2010-12-31$0.43 B-9%
2009-12-31$0.47 B27.75%
2008-12-31$0.37 B-27.47%
2007-12-31$0.51 B-5.63%
2006-12-31$0.54 B1.76%
2005-12-31$0.53 B91.56%
2004-12-31$0.27 B-38.67%
2003-12-31$0.45 B13.19%
2002-12-31$0.39 B0.74%
2001-12-31$0.39 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
$80.52 B 37,133.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$115.63 B 53,370.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$77.63 B 35,800.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
$40.69 M-81.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$68.48 B 31,567.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
$13.85 B 6,305.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
$0.59 B 175.63%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
$113.53 B 52,400.91%๐Ÿ‡บ๐Ÿ‡ธ USA